Loading clinical trials...

COMPLETEDPhase 2NCT01538979

Phase II Study of Grass Pollen Allergy Vaccine BM32

The study will evaluate the efficacy and safety of BM32 in grass pollen allergic subjects. It will test the hypothesis that either of two doses of BM32 will lead to a sustained relief off allergy symp...

Lead sponsor: Biomay AG•11 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

GRASS (Grass MATA MPL Real-world Assessment Study)

NCT07412990 · Grass Pollen Allergy

COMPLETEDPhase 2

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy

COMPLETEDNA

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

NCT05560698 · Grass Pollen Allergy, Rhinoconjunctivitis

COMPLETEDNA

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens

NCT04435678 · Birch Pollen Allergy, Grass Pollen Allergy, and more

COMPLETED

Regulatory T-cells After Subcutaneous Immunotherapy

NCT01830673 · Grass Pollen Allergy, Specific Immunotherapy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 18, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment181

Start dateMar 2012

Last updatedDec 18, 2015

Condition

Grass Pollen Allergy

Locations shown

Medical University

Vienna, Vienna

Universitätsklinik für Dermatologie und Allergologie

Graz

Allergy Network Ghent University Hospital Ghent, Dept. Otorhiolaryngologie

Ghent

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 18, 2015Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions